Cadence Neuroscience
Doug Sheffield is a seasoned expert in clinical and preclinical research, currently serving as the Chief Scientific Officer at Cadence Neuroscience Inc. since May 2017. With a robust background in clinical affairs, Sheffield previously held the position of Executive Director at Spiration, Inc., where responsibilities included leading clinical strategy and ensuring regulatory compliance. At Sheffield Consulting, consulting services focused on preclinical and early-stage medical device companies. Prior roles include VP of Clinical Research at NeuroVista, Director of New Technology at Northstar Neuroscience, and multiple directorships at Ethicon and Ethicon Endo-Surgery. Doug Sheffield holds advanced degrees from The Johns Hopkins University and the University of Pennsylvania, underscoring a strong foundation in veterinary medicine and pathology.
This person is not in the org chart
This person is not in any teams
Cadence Neuroscience
Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with a procedure thatcan be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols. Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington.